BH4 domain of Bcl-2 as a novel target for cancer therapy
Author:
Funder
National Institutes of Health
NIGMS
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference68 articles.
1. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy;Czabotar;Nat. Rev. Mol. Cell Biol.,2014
2. Small-molecule Bax agonists for cancer therapy;Xin;Nat. Commun.,2014
3. Direct activation of Bax protein for cancer therapy;Liu;Med. Res. Rev.,2015
4. Docetaxel-based combination therapy for castration-resistant prostate cancer;Galsky;Annal. Oncol.,2010
5. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy;Kang;Clin. Cancer Res.,2009
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, Synthesis, and in-silico Studies of New Disubstituted Benzimidazoles: Evaluation of In-vitro Anticancer and Antimicrobial Activity;INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY;2024-03
2. Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca2+ traffic and response to neoadjuvant chemotherapy;Cell Death & Disease;2023-07-01
3. CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth;BMC Cancer;2023-05-26
4. Biochemical, hematological, peripheral smear and weight evaluation of low dose Epigallocatechin Gallate in Diethylnitrosamine administered rats;Journal of Contemporary Medicine;2023-03-22
5. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies;Cells;2023-03-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3